Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Am J Trop Med Hyg ; 75(6): 1135-9, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17172381

RESUMEN

An IgG avidity assay was developed to differentiate deer mice that had recently acquired Sin Nombre virus (SNV) from those that were infected in the distant past. Using this procedure, low avidity antibodies were predominantly detected in experimentally infected deer mice (89.5%) within the first 30 days post-inoculation. The assay was then applied to sera from naturally infected deer mice collected during a field investigation associated with a cluster of hantavirus pulmonary syndrome cases. A higher proportion of seropositive mice collected during the outbreak had serum with low avidity antibodies (16.7%) when compared with mice trapped four months later (5.7%). Sin Nombre virus RNA was detectable in blood in a similar fraction of low- (45%) and high- (38.7%) avidity groups. Non-adult mice were more likely to contain low-avidity antibodies (44.4%) than were adults (9.6%). Our results indicate that the IgG avidity assay shows promise as a tool to better characterize epizootic intensity and to identify factors involved in SNV transmission.


Asunto(s)
Afinidad de Anticuerpos/inmunología , Síndrome Pulmonar por Hantavirus/transmisión , Inmunoglobulina G/inmunología , Peromyscus/virología , Virus Sin Nombre/inmunología , Animales , Ensayo de Inmunoadsorción Enzimática , Humanos , ARN Viral/aislamiento & purificación , Reproducibilidad de los Resultados
2.
J Gen Virol ; 88(Pt 2): 493-505, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17251568

RESUMEN

The New World hantavirus Sin Nombre virus (SNV) is an aetiological agent for the often-fatal hantavirus cardiopulmonary syndrome (HCPS). There is no disease model for SNV and specific treatments for HCPS do not exist. By using the deer mouse infectious model, the in vivo inhibitory potential of ribavirin, human anti-SNV immune plasma (HIP), an anti-beta3 antibody (ReoPro) and a polyclonal rabbit anti-recombinant nucleocapsid (N) antibody against SNV was investigated. Concurrent intraperitoneal administration of 100 mg ribavirin kg(-1) prevented seroconversion in all mice at day 15 post-inoculation (p.i.). No evidence of infection was detectable by immunohistochemical staining or by quantitative RT-PCR in two of these six mice. Lower doses of ribavirin, between 5 and 50 mg kg(-1), were much less effective at inhibiting infection. Mice given 200 microl aliquots of dilutions as high as 1 : 20 of HIP (neutralizing-antibody titre 800) failed to seroconvert by day 15 p.i. SNV N antigen staining and viral S genome were undetectable in these mice. A subset of mice given higher dilutions of HIP became infected. Treatment with 6 mg ReoPro kg(-1) did not prevent seroconversion, but was able to reduce viral load. Mice treated with 200 microl anti-N antibody or negative human plasma seroconverted when challenged with SNV, and antigen staining and viral loads were comparable to those seen in untreated controls. These results show that ReoPro can lower viral loads and that ribavirin and HIP, but not anti-N antibody, inhibit seroconversion and reduce viral loads in a dose-dependent manner.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Antivirales/uso terapéutico , Modelos Animales de Enfermedad , Síndrome Pulmonar por Hantavirus/tratamiento farmacológico , Sueros Inmunes/administración & dosificación , Fragmentos Fab de Inmunoglobulinas/uso terapéutico , Ribavirina/uso terapéutico , Virus Sin Nombre/patogenicidad , Abciximab , Animales , Anticuerpos/inmunología , Anticuerpos/uso terapéutico , Anticuerpos Monoclonales/administración & dosificación , Antivirales/administración & dosificación , Síndrome Pulmonar por Hantavirus/inmunología , Síndrome Pulmonar por Hantavirus/virología , Humanos , Fragmentos Fab de Inmunoglobulinas/administración & dosificación , Integrina beta3/inmunología , Peromyscus , Conejos , Ribavirina/administración & dosificación , Resultado del Tratamiento
3.
Proc Natl Acad Sci U S A ; 104(39): 15496-501, 2007 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-17875986

RESUMEN

Hantavirus cardiopulmonary syndrome is a zoonotic illness associated with a systemic inflammatory immune response, capillary leak, noncardiogenic pulmonary edema, and shock in humans. Cytokines, including TNF, IFN-gamma, and lymphotoxin, are thought to contribute to its pathogenesis. In contrast, infected rodent reservoirs of hantaviruses experience few or no pathologic changes and the host rodent can remain persistently infected for life. Generally, it is unknown why such dichotomous immune responses occur between humans and reservoir hosts. Thus, we examined CD4(+) T cell responses from one such reservoir, the deer mouse (Peromyscus maniculatus), infected with Sin Nombre virus. Proliferation responses to viral nucleocapsid antigen were relatively weak in T cells isolated from deer mice, regardless of acute or persistent infection. The T cells from acutely infected deer mice synthesized a broad spectrum of cytokines, including IFN-gamma, IL-4, IL-5, and TGF-beta(1), but not TNF, lymphotoxin, or IL-17. However, in T cells from persistently infected deer mice, only TGF-beta(1) was expressed by all lines, whereas some expressed reduced levels of IFN-gamma or IL-5. The Forkhead box P3 transcription factor, a marker of some regulatory T cells, was expressed by most of these cells. Collectively, these data suggest that TGF-beta(1)-expressing regulatory T cells may play an important role in limiting immunopathology in the natural reservoir host, but this response may interfere with viral clearance. Such a response may have arisen as a mutually beneficial coadaptive evolutionary event between hantaviruses and their rodent reservoirs, so as to limit disease while also allowing the virus to persist.


Asunto(s)
Virus Sin Nombre/metabolismo , Linfocitos T Reguladores/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Orthohantavirus/metabolismo , Interferón gamma/metabolismo , Interleucina-17/metabolismo , Interleucina-4/metabolismo , Interleucina-5/metabolismo , Ratones , Modelos Biológicos , Peromyscus , ARN Viral/metabolismo , Linfocitos T/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA